Measures of Sleep in Rheumatologic Diseases: Sleep Quality Patient‐Reported Outcomes in Rheumatologic Diseases

Chu, Philip; Ju, Yo‐El S.; Hinze, Alicia M.; Kim, Alfred H.J.

doi:10.1002/acr.24238

Cited by 3 publications

(1 citation statement)

References 183 publications

(282 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Compared with the general population, SLE patients report poorer perceived sleep quality [ 2–6 ], with a prevalence of sleep disturbances ranging from 56 to 80.5% [ 5 ]. In SLE patients, sleep has been mainly investigated through subjective methods, the Pittsburgh Sleep Quality Index (PSQI) being the most widely used [ 2 , 5 , 7 ]. Only a few studies have investigated sleep through objective methods such as actigraphy or polysomnography (PSG) [ 8–13 ].…”

Section: Introductionmentioning

confidence: 99%

Actigraphic and self-reported characterization of sleep in systemic lupus erythematosus patients

Faraguna,

Porciani,

Colitta

et al. 2023

Rheumatology

View full text Add to dashboard Cite

Objective In a cross-sectional study, we explored possible differences in sleep parameters between Systemic Lupus Erythematosus (SLE) patients and age- and gender-matched healthy controls through actigraphic and self-reported measures. Furthermore, we aimed at identifying possible predictors of such disturbances in the patients’ cohort. Methods Participants’ sociodemographic data and sleep parameters were collected. Sleep parameters were evaluated through the Pittsburgh Sleep Quality Index, the Insomnia Severity Index (ISI) and a 7-day actigraphic monitoring. The Perceived Stress Scale-10 was used to investigate stress. Disease activity and daily glucocorticoid dose were assessed in SLE patients. Possible predictors of the SLE group were explored through two binomial logistic models. Within the SLE group, possible predictors of sleep parameters were tested estimating multiple linear regression models. Results 40 SLE patients and 33 controls were included in the study. SLE group showed worse sleep maintenance actigraphic parameters (i.e., sleep efficiency and wake after sleep onset), higher total sleep time and higher perceived stress. Within the SLE cohort, daily glucocorticoids dose was associated with an impairment in sleep maintenance despite no reduction in sleep duration, typical of normal sleep duration insomnia, whereas perceived stress was associated with short sleep duration insomnia. Conclusion Compared to healthy controls, SLE patients showed worse sleep quality and greater perceived stress severity. As glucocorticoids and perceived stress promote different types of insomnia in these patients, a multidimensional approach to both sleep characterization and therapy might hence be preferred.

show abstract

Section: Introductionmentioning

confidence: 99%

Actigraphic and self-reported characterization of sleep in systemic lupus erythematosus patients

Faraguna,

Porciani,

Colitta

et al. 2023

Rheumatology

View full text Add to dashboard Cite

show abstract

Reduced sleep quality is highly prevalent and associated with physical function and cardiorespiratory fitness in patients with axial spondyloarthritis: a cross-sectional study

Fongen,

Dagfinrud,

Bilberg

et al. 2023

Scandinavian Journal of Rheumatology

View full text Add to dashboard Cite

Prevalence of sleep disturbance in patients with ankylosing spondylitis: a systematic review and meta-analysis

et al. 2023

View full text Add to dashboard Cite

Background Ankylosing Spondylitis (AS) patients face several challenges due to the nature of the disease and its physical and psychological complications. Sleep disorders are among the most important concerns. Sleep disorders can aggravate the signs and symptoms of the disease and ultimately reduce the quality of patients’ lives. This study uses a systematic review and meta-analysis to pool the reported prevalence of sleep disorders among AS patients. Methods To find related studies, the WoS, PubMed, ScienceDirect, Scopus, Embase, and Google Scholar databases were systematically searched without a lower time limit. Heterogeneity among the identified studies was checked using the I2 index, and the Begg and Mazumdar correlation test examined the existence of published bias. Comprehensive Meta-Analysis (v.2) software was adopted to analyze the data. Results In the review of 18 studies with a sample size of 5,840, the overall pooled prevalence of sleep disorders among AS patients based on the random effects method was found to be 53% (95% CI: 44.9–61). The highest and lowest prevalence was in Egypt at 90% and Australia at 19.2%, respectively. Our meta-regression results show that with the increase in ‘sample size’ and ‘year of publication’, the overall prevalence of sleep disorders in patients with AS decreases (p < 0.05). Conclusion The results of the present study indicate a high and significant prevalence of sleep disorders among AS patients. Thus, health policymakers and healthcare providers must focus on timely diagnosis and effective educational and therapeutic interventions for the prevention and proper treatment of sleep disorders in this population of patients.

show abstract

Measures of Sleep in Rheumatologic Diseases: Sleep Quality Patient‐Reported Outcomes in Rheumatologic Diseases

Cited by 3 publications

References 183 publications

Actigraphic and self-reported characterization of sleep in systemic lupus erythematosus patients

Actigraphic and self-reported characterization of sleep in systemic lupus erythematosus patients

Reduced sleep quality is highly prevalent and associated with physical function and cardiorespiratory fitness in patients with axial spondyloarthritis: a cross-sectional study

Prevalence of sleep disturbance in patients with ankylosing spondylitis: a systematic review and meta-analysis

Contact Info

Product

Resources

About